TScan Therapeutics Inc. (TCRX)
NASDAQ · Healthcare
TScan Therapeutics Inc. Net Income 2020–2025
TScan Therapeutics Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- TScan Therapeutics Inc. net income for the quarter ending March 31, 2026 was -28.7 M, a 16.00% decrease year-over-year.
- TScan Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -135.5 M, a 18.11% increase year-over-year.
- TScan Therapeutics Inc. annual net income for 2025 was -129.8 M, a 1.78% increase from 2024.
- TScan Therapeutics Inc. annual net income for 2024 was -127.5 M, a 42.91% increase from 2023.
- TScan Therapeutics Inc. annual net income for 2023 was -89.2 M, a 34.73% increase from 2022.
- TScan Therapeutics Inc. annual net income for 2022 was -66.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
TScan Therapeutics Inc. Net Income — FAQ
TScan Therapeutics Inc. (TCRX) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is TScan Therapeutics Inc.'s net income?
TScan Therapeutics Inc. (TCRX) reported net income of -$130M for fiscal 2025.
Where can I see TCRX's net income history?
The chart and table above show TScan Therapeutics Inc.'s net income by year and by quarter, including the growth rate.